Mondelez International, Inc.

Comprehensive Analysis of MDLZ (Mondelez International)

Technical Analysis MDLZ has shown encouraging short-term momentum, gaining over 6% in the last month and outperforming the market by a notable margin. Its low beta indicates stability, while the current price near the middle of its 52-week range suggests a balanced entry point. The stock has partially recovered from earlier declines, hinting at gradual strength without being overextended.

Fundamentals Revenue and profitability improved in recent quarters, with growing margins and disciplined cost control. The company maintains manageable debt levels and strong interest coverage, though its working capital ratios are tight. Healthy free cash flow supports shareholder returns, evidenced by a high payout ratio, underscoring steady operational performance.

Valuation MDLZ trades at a premium with elevated P/E ratios, which may reflect high expectations. However, a negative PEG ratio raises concerns about whether growth justifies the valuation. Missing peer comparison data limits context, but cautious investors might view current levels as rich without clearer growth catalysts.

Risk With a low beta, MDLZ offers relative stability amid market swings, but its significant past drawdown highlights vulnerability during downturns. Low short interest implies market confidence, yet sector-wide pressures or liquidity constraints could pose subtle risks.

---

Buy Recommendation

MDLZ presents a compelling case for conservative investors seeking stability and income, given its solid fundamentals, improving profitability, and strong cash flow. While the valuation appears stretched, the stock’s defensive qualities and recent momentum offer a balanced risk-reward profile. For long-term portfolios prioritizing steady returns over rapid growth, MDLZ is worth considering as a resilient consumer staples holding.

*Note: This is not investment advice, for reference only.*

RockFlow Model Forecast: Three Scenarios for 2026

Based on the provided analysis, the 12-month outlook for Mondelez International (MDLZ) is cautiously optimistic, favoring stability over aggressive growth. Key positive catalysts include its improving profitability, strong free cash flow supporting shareholder returns, and defensive qualities as a consumer staples leader, which should provide resilience. The primary risk is its premium valuation, which may limit significant upside without clearer growth catalysts to justify the high P/E ratio. While a specific analyst target isn't provided, the stock's balanced technical position and low beta suggest a target range in the mid-to-high $60s, representing moderate upside from the current $61.34, contingent on sustained execution and market stability.

Wall Street Consensus

Most Wall Street analysts are optimistic about Mondelez International, Inc.'s 12-month outlook, with consensus target around $61.58, indicating expected upside potential.

Overall, MDLZ has investment potential but also faces challenges. Here are key factors to weigh before investing.

MDLZ has demonstrated strong recent performance through a notable rebound, though it remains below its 52-week peak following a significant drawdown over the past year.

The stock has shown impressive short-term momentum, gaining over 6% in the last month and nearly 8% over three months, significantly outperforming the broader market by 3.59%. This robust performance, combined with its low beta, suggests steady, low-volatility strength relative to market swings.

Currently trading at $61.34, MDLZ sits approximately in the middle of its 52-week range, indicating a neutral position that is neither overbought nor oversold. The price recovery has retraced a portion of the prior 27% drawdown, pointing to a stabilized but not yet fully recovered state relative to its annual high.

Revenue & Profitability Mondelez demonstrated sequential revenue growth from $9.74B in Q3 to $10.50B in Q4 2025, indicating positive momentum. Profitability metrics improved with gross margin expanding from 26.8% to 28.2% and operating margin strengthening from 7.6% to 9.3% quarter-over-quarter. The net profit margin of 6.3% reflects solid bottom-line performance despite a higher effective tax rate of 28.1%.

Financial Health The company maintains moderate leverage with a debt-to-equity ratio of 0.87 and total debt to capitalization of 46.4%, indicating manageable debt levels. Strong interest coverage of 18.1x demonstrates ample earnings capacity to service debt obligations. However, the current ratio of 0.59 and quick ratio of 0.39 suggest relatively tight working capital management.

Operational Efficiency Mondelez shows modest operational efficiency with ROE of 2.6% and asset turnover of 0.15, reflecting the capital-intensive nature of the consumer staples industry. The negative cash conversion cycle of -26.6 days is noteworthy, indicating the company collects from customers before paying suppliers. Free cash flow generation appears healthy with $1.55 per share, supporting the shareholder-friendly 97% payout ratio.

Based purely on valuation metrics, MDLZ appears to be trading at a premium. The TTM and Forward P/E ratios of 31.16 and 26.09, respectively, are elevated for a consumer staples company, suggesting investors are pricing in high earnings growth. However, this is contradicted by the significantly negative PEG ratio of -2.97, which typically indicates that expected growth does not justify the high earnings multiple, pointing to potential overvaluation at current levels.

A comprehensive peer comparison cannot be accurately performed as the requisite industry average data is unavailable. Without contextual benchmarks for P/E, P/B, or EV/EBITDA ratios, it is impossible to determine how MDLZ's valuation multiples stack up against its direct competitors. Therefore, the assessment remains incomplete and should be considered with the caveat that a full industry relative analysis is not possible.

Volatility Risk: MDLZ exhibits low volatility risk, as evidenced by its Beta of 0.401, indicating the stock is significantly less volatile than the broader market. However, the one-year maximum drawdown of -27.19% demonstrates that the stock is still subject to substantial peak-to-trough declines during market downturns, highlighting a potential for capital depreciation during adverse periods.

Other Risks: The absence of significant short interest suggests market consensus on the company's stability and lack of immediate bearish catalysts. While this is positive, investors should remain attentive to other factors such as liquidity, which, while typically robust for a large-cap stock like MDLZ, could be impacted by broader market stress or sector-specific challenges affecting consumer staples.